Ketamine - thblack.com
... David and Shipp (2010): RCT comparing propofol versus propofol/ketamine for procedural sedation analyzing respiratory depression, provider satisfaction, amount of propofol administered and sedation quality. Ketamine dose was 0.5 mg/kg or placebo was given, then followed by propofol 1 mg/kg with repe ...
... David and Shipp (2010): RCT comparing propofol versus propofol/ketamine for procedural sedation analyzing respiratory depression, provider satisfaction, amount of propofol administered and sedation quality. Ketamine dose was 0.5 mg/kg or placebo was given, then followed by propofol 1 mg/kg with repe ...
Neuropharmacology of N,N-dimethyltryptamine
... hallucinogenic compounds taken and lack adequate records of DMT-specific cases. Street drugs mostly contain powdered DMT, whereas ayahuasca also contains harmine-related compounds, which limit toxic effects (Lanaro et al., 2015). However, aside from the acute cardiovascular effects there have been no ...
... hallucinogenic compounds taken and lack adequate records of DMT-specific cases. Street drugs mostly contain powdered DMT, whereas ayahuasca also contains harmine-related compounds, which limit toxic effects (Lanaro et al., 2015). However, aside from the acute cardiovascular effects there have been no ...
![Full Text [Download PDF]](http://s1.studyres.com/store/data/002022957_1-66fe2116d95b7f5da3ee36594fc93517-300x300.png)
Full Text [Download PDF]
... natriuretic peptide (BNP) proteins, myocardin mRNA, angiotensin II (AngII), and superoxide dismutase (SOD) expressions were up-regulated in the banding group, which were inhibited by atorvastatin, valsartan, NAC, and the three agents combined. Increased immunohistochemical labelings of myocardin and ...
... natriuretic peptide (BNP) proteins, myocardin mRNA, angiotensin II (AngII), and superoxide dismutase (SOD) expressions were up-regulated in the banding group, which were inhibited by atorvastatin, valsartan, NAC, and the three agents combined. Increased immunohistochemical labelings of myocardin and ...
8 Ultra-low-dose opioid antagonists enhance opioid analgesia while
... "gooseflesh," and itching (Miser et al., 1986; Heit, 2003). Abrupt cessation of opioid treatment can also cause a hyperalgesia, which has also been called opioidinduced hyperalgesia (Li et al., 2001). While patients receiving prolonged opioid analgesic therapy may or may not develop analgesic tolera ...
... "gooseflesh," and itching (Miser et al., 1986; Heit, 2003). Abrupt cessation of opioid treatment can also cause a hyperalgesia, which has also been called opioidinduced hyperalgesia (Li et al., 2001). While patients receiving prolonged opioid analgesic therapy may or may not develop analgesic tolera ...
